ArticleJAAD international2023

Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks.

Michael Migden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.